-
Comprehensive Corporate Representation
Jason’s practice covers a broad range of general corporate and transactional matters.
Jason Skolnik is a corporate and securities partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. His practice covers a broad range of general corporate and transactional matters, including mergers and acquisitions and other strategic transactions, venture capital financings, joint ventures, public offerings and disclosure matters, corporate finance, and corporate advisory work. Jason represents companies at all stages of their life cycle, from start-ups to public companies, primarily in the life sciences and technologies industries. He also represents venture capital, growth equity, and private equity funds.
Jason Skolnik is a corporate and securities partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. His practice covers a broad range of general corporate and transactional matters, including mergers and acquisitions and other strategic transactions, venture capital financings, joint ventures, public offerings and disclosure matters, corporate finance, and corporate advisory work. Jason represents companies at all stages of their life cycle, from start-ups to public companies, primarily in the life sciences and technologies industries. He also represents venture capital, growth equity, and private equity funds.
- J.D., Loyola Law SchoolMagna Cum Laude; Order of the Coif; Sayre Macneil Scholar; Articles Editor, Loyola of Los Angeles Law Review
- B.S., Applied Economics and Business Management, Cornell UniversityCum Laude
- State Bar of California
- J.D., Loyola Law SchoolMagna Cum Laude; Order of the Coif; Sayre Macneil Scholar; Articles Editor, Loyola of Los Angeles Law Review
- B.S., Applied Economics and Business Management, Cornell UniversityCum Laude
- State Bar of California
Select Transactions
Venture Financings
- Galvanize Therapeutics in its $100 million Series C financing and $100 million Series B financing
- SpectraWAVE in its $50 million Series B financing
- Empirico in its $45 million Series B financing
- DermBiont in its $35 million Series B financing
- Aethon, Aulos, Deep Apple, Evercrisp, Initial, Nereid, Replicate and other companies in their venture creations and Series A financings with Apple Tree Partners
- Ventyx in its $114 million Series A financing
- uLab in its $54 million Series E financing
- ComplianceMetrix in its $50 million Series A financing
- Tempo Therapeutics in its $12 million Series A financing
M&A Transactions
- SpectraWAVE in its sale to Philips
- View Point Medical in its sale to Merit Medical
- Statrad in its sale to i-Med
- Discover Echo in its sale to Bico
- Galvanize in its sale of its electrophysiology division to CardioFocus
- Cure Medical in its sale to ConvaTec
- Tusker Medical in its sale to Smith & Nephew
- Cianna Medical in its sale to Merit Medical
- Vertiflex in its sale to Boston Scientific
- Vertuis Bio in its sale to Innsmed
- Palamedrix in its sale to SomaLogic
- Geneva in its sale to BioTelemetry
- Balt in its acquisitions of Blockade Medical and Neurvana Medical
- Thuasne in its acquisitions of Quinn Medical, Knit-Rite and Lantz Medical
- MaxLinear in its acquisitions of Entropic and Nanosemi
Initial Public Offerings
- RxSight in its initial public offering
- Ventyx in its initial public offering
Select Transactions
Venture Financings
- Galvanize Therapeutics in its $100 million Series C financing and $100 million Series B financing
- SpectraWAVE in its $50 million Series B financing
- Empirico in its $45 million Series B financing
- DermBiont in its $35 million Series B financing
- Aethon, Aulos, Deep Apple, Evercrisp, Initial, Nereid, Replicate and other companies in their venture creations and Series A financings with Apple Tree Partners
- Ventyx in its $114 million Series A financing
- uLab in its $54 million Series E financing
- ComplianceMetrix in its $50 million Series A financing
- Tempo Therapeutics in its $12 million Series A financing
M&A Transactions
- SpectraWAVE in its sale to Philips
- View Point Medical in its sale to Merit Medical
- Statrad in its sale to i-Med
- Discover Echo in its sale to Bico
- Galvanize in its sale of its electrophysiology division to CardioFocus
- Cure Medical in its sale to ConvaTec
- Tusker Medical in its sale to Smith & Nephew
- Cianna Medical in its sale to Merit Medical
- Vertiflex in its sale to Boston Scientific
- Vertuis Bio in its sale to Innsmed
- Palamedrix in its sale to SomaLogic
- Geneva in its sale to BioTelemetry
- Balt in its acquisitions of Blockade Medical and Neurvana Medical
- Thuasne in its acquisitions of Quinn Medical, Knit-Rite and Lantz Medical
- MaxLinear in its acquisitions of Entropic and Nanosemi
Initial Public Offerings
- RxSight in its initial public offering
- Ventyx in its initial public offering
- Privacy Policy
- Terms of Use
- Accessibility